{"id":13872,"date":"2025-01-06T11:08:38","date_gmt":"2025-01-06T11:08:38","guid":{"rendered":"https:\/\/distilinfo.com\/healthplan\/?p=13872"},"modified":"2025-01-08T14:21:09","modified_gmt":"2025-01-08T14:21:09","slug":"pharmaceutical-giants-face-historic-price-fixing-legal-battle","status":"publish","type":"post","link":"https:\/\/distilinfo.com\/healthplan\/pharmaceutical-giants-face-historic-price-fixing-legal-battle\/","title":{"rendered":"Pharmaceutical Giants Face Historic Price-Fixing Legal Battle"},"content":{"rendered":"

The Core Controversy<\/strong><\/p>\n

In a groundbreaking legal development, Aetna has initiated litigation against several pharmaceutical powerhouses, including Pfizer, Novartis, and Teva Pharmaceuticals<\/a>. The lawsuit centers on allegations of systematic price manipulation and market share conspiracy for generic medications.<\/p>\n

Evidence and Timeline<\/strong><\/p>\n

Beginning in 2012, these pharmaceutical companies allegedly engaged in covert communications during trade conferences and phone conversations. The complaint suggests a deliberate pattern of evidence destruction when written communications were involved.<\/p>\n

Market Manipulation Tactics<\/strong><\/p>\n

The pharmaceutical companies reportedly employed sophisticated strategies to maintain artificial price equilibrium:<\/p>\n